Humana Inc. HUM
Set alert
As of Nov 3, 1:48 PM ET
- YTD
- +62.76%
- 1 year
- +48.93%
- Open
- 407.87
- Prev close
- 410.41
- Mkt cap
- 50.03B
- Vol
- 459.08K
- Avg vol
- 1.24M
- EPS
- 10.58
- P/E
- 39.38
- Div yield
- 0.85%
More statistics
- Low
- 407.36
- High
- 419.55
- Forward P/E
- 24.01
- Beta
- 0.64
- Short ratio
- 2.41
- Inst. own
- 101.38%
- Dividend
- 3.54
- Ex-div date
- Dec 23, 2026
- Earnings
- Nov 6, 2026
- 50-d avg
- 401.03
- 200-d avg
- 308.34
- 1y target
- 465.13
15m chart
Built from the cached five-day intraday bars.
Events in this range
- Oct 30, 2026Dividend: 0.885
Signals (37)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 12:55 PM | 53 minutes ago |
| SMA: Bearish | Nov 3, 12:40 PM | 1 hour ago |
| RSI: Overbought | Nov 3, 11:55 AM | 1 hour ago |
| SMA: Bullish | Nov 2, 3:10 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 1:40 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 1:40 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 9:55 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:40 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:40 AM | 1 day ago |
| SMA: Bullish | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:40 PM | 4 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 4 days ago |
| SMA: Bullish | Oct 30, 1:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 30, 1:55 PM | 4 days ago |
| SMA: Bearish | Oct 30, 12:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 30, 12:40 PM | 4 days ago |
| SMA: Bullish | Oct 30, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 30, 11:25 AM | 4 days ago |
Newest 20 of 37.
Key statistics
- Market cap
- 49.27B
- Enterprise value
- 40.71B
- Trailing P/E
- 38.78
- Forward P/E
- 24.01
- PEG ratio
- 1.14
- Price / sales
- 0.34
- Price / book
- 2.56
- EPS (TTM)
- 10.58
- Beta
- 0.64
- Dividend yield
- 0.85%
- Payout ratio
- 33.46%
- Profit margin
- 0.88%
- Revenue (TTM)
- 145.68B
- Revenue growth
- 26.20%
- Free cash flow
- 1.94B
- Total cash
- 23.87B
- Total debt
- 14.74B
- Return on equity
- 6.89%
- Shares outstanding
- 120.08M
- Short % of float
- 3.47%
- 50-day average
- 401.03
- 200-day average
- 308.34
Analyst view
Consensus: buy
- Target (low)
- 280.00
- Target (mean)
- 465.13
- Target (high)
- 596.00
- Strong buy3
- Buy13
- Hold9
- Sell1
- Strong sell0
Next earnings
Nov 6, 2026
Expected Nov 6, 2026. Consensus EPS estimate -1.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2026 | Sep 30, 2026 | -1.00 | — | — | — |
| Jul 29, 2026 | Jun 30, 2026 | 7.27 | 7.61 | +0.34 | +4.68% |
| Apr 29, 2026 | Mar 31, 2026 | 10.24 | 10.31 | +0.07 | +0.68% |
| Feb 11, 2026 | Dec 31, 2025 | -4.00 | -3.96 | +0.04 | +1.00% |
| Nov 5, 2025 | Sep 30, 2025 | 2.93 | 3.24 | +0.31 | +10.58% |
| Jul 30, 2025 | Jun 30, 2025 | 5.92 | 6.27 | +0.35 | +5.91% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Mizuho | main | Outperform | Outperform |
| Oct 12, 2026 | UBS | main | Neutral | Neutral |
| Oct 12, 2026 | Truist Securities | main | Hold | Hold |
| Oct 12, 2026 | Oppenheimer | main | Outperform | Outperform |
| Oct 12, 2026 | Raymond James | up | Market Perform | Outperform |
| Oct 9, 2026 | Barclays | main | Overweight | Overweight |
About Humana Inc.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- humana.com
News
- Humana And athenahealth Expand Electronic Prior Authorization Capabilities Across athenahealth’s Network Of 180K+ Physicians And Clinicians
- Humana and athenahealth expand electronic prior authorization capabilities nationwide, reducing administrative burden for physicians and helping patients access care faster
- Why Humana (HUM) Could Beat Earnings Estimates Again
- Analysts Estimate Humana (HUM) to Report a Decline in Earnings: What to Look Out for
- Humana Board Declares Payment of Quarterly Dividend to Stockholders
- Baron Health Care Fund: Q3 2026 New Positions And Exits
- Humana Gains From Premium Growth Despite Rising Benefit Costs
- Meta Is About to Show Whether Bigger AI Capex Still Wins
- Should Value Investors Buy Humana (HUM) Stock?
- 3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking
Your note
Sign in to keep a note on HUM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN CELESTE M | Chief Financial Officer | Stock Award(Grant) | Feb 12, 2025 | 23,291 |
| DIAMOND SUSAN M | Chief Financial Officer | Conversion of Exercise of derivative security | Dec 12, 2024 | 22,378 |
| DINTENFASS DAVID | Officer | Stock Award(Grant) | Apr 30, 2026 | 25,407 |
| MARTIN AARON | Officer | Stock Award(Grant) | Apr 30, 2026 | 25,237 |
| MEHTA JAPAN | Chief Technology Officer | Stock Award(Grant) | Apr 30, 2026 | 17,176 |
| MELLET CELESTE | Chief Financial Officer | Stock Award(Grant) | Apr 30, 2026 | 39,637 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Inc. | 9.11% | 10,940,380 | 4.49B | Jun 29, 2026 |
| Blackrock Inc. | 8.68% | 10,417,803 | 4.27B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 7,843,620 | 3.22B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.85% | 5,818,956 | 2.39B | Jun 29, 2026 |
| State Street Corporation | 4.54% | 5,457,072 | 2.24B | Jun 29, 2026 |
| Eagle Capital Management LLC | 3.20% | 3,846,762 | 1.58B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 6.12% | 7,354,500 | 3.02B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 3,811,711 | 1.56B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 3,111,659 | 1.28B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 2,601,473 | 1.07B | Jun 29, 2026 |
| AMERICAN FUNDS FUNDAMENTAL INVESTORS | 1.41% | 1,690,812 | 693.79M | Sep 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 1,600,377 | 656.68M | Sep 29, 2026 |